Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4551
Aemetis
AMTX
$99.2M
| $57K | ﹤0.01% |
3,137
+2,033
| +184% | +$22.5K |
|
4552
Duluth Holdings
DLTH
$152M
| $57K | ﹤0.01% |
4,210
+3,203
| +318% | +$51.1K |
|
|
EH
4553
EHang Holdings
EH
$375M
| $57K | ﹤0.01% |
2,386
-626
| -21% | -$17.1K |
|
4554
GCM Grosvenor
GCMG
$737M
| $57K | ﹤0.01% |
4,967
+3,411
| +219% | +$37K |
|
4555
Hingham Institution for Saving
HIFS
$624M
| $57K | ﹤0.01% |
169
+100
| +145% | +$31.2K |
|
4556
MediaAlpha
MAX
$746M
| $57K | ﹤0.01% |
3,038
+1,771
| +140% | +$48K |
|
4557
Oportun Financial
OPRT
$262M
| $57K | ﹤0.01% |
2,291
+1,099
| +92% | +$25.3K |
|
4558
Spyre Therapeutics
SYRE
$8.5B
| $57K | ﹤0.01% |
285
+86
| +43% | +$15K |
|
|
AKUS
4559
DELISTED
Akouos Inc
AKUS
| $57K | ﹤0.01% |
4,870
+599
| +14% | +$7.18K |
|
4560
Ceragon Networks
CRNT
$188M
| $56K | ﹤0.01% |
16,088
-1,008
| -6% | -$3.81K |
|
|
DCBO
4561
Docebo
DCBO
$559M
| $56K | ﹤0.01% |
+769
| New | +$56.5K |
|
4562
GS ActiveBeta US Small Cap Equity ETF
GSSC
$1.04B
| $56K | ﹤0.01% |
893
-79
| -8% | -$5.02K |
|
4563
Nuveen Preferred & Income Opportunities Fund
JPC
$2.88B
| $56K | ﹤0.01% |
5,622
-13,699
| -71% | -$137K |
|
4564
Nomura Holdings
NMR
$28.3B
| $56K | ﹤0.01% |
11,212
-90,235
| -89% | -$451K |
|
4565
Nuveen ESG Mid-Cap Growth ETF
NUMG
$348M
| $56K | ﹤0.01% |
1,021
-226
| -18% | -$12.6K |
|
4566
Tidewater
TDW
$3.63B
| $56K | ﹤0.01% |
4,662
+2,729
| +141% | +$31K |
|
4567
ROBO Global Artificial Intelligence ETF
THNQ
$396M
| $56K | ﹤0.01% |
1,300
| – | – |
|
|
SPNE
4568
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $56K | ﹤0.01% |
3,561
+2,049
| +136% | +$35.1K |
|
4569
American Superconductor
AMSC
$1.29B
| $55K | ﹤0.01% |
3,791
+2,471
| +187% | +$34.3K |
|
4570
Bar Harbor Bankshares
BHB
$665M
| $55K | ﹤0.01% |
1,963
-579
| -23% | -$16K |
|
4571
Traeger
COOK
$165M
| $55K | ﹤0.01% |
+53
| New | +$66.1K |
|
4572
Krispy Kreme
DNUT
$562M
| $55K | ﹤0.01% |
+3,953
| New | +$63.4K |
|
|
KZR
4573
DELISTED
Kezar Life Sciences
KZR
| $55K | ﹤0.01% |
632
+165
| +35% | +$10.9K |
|
|
SABA
4574
Saba Capital Income & Opportunities Fund II
SABA
$220M
| $55K | ﹤0.01% |
5,128
-18,740
| -79% | -$206K |
|
4575
West Bancorporation
WTBA
$477M
| $55K | ﹤0.01% |
1,834
+1,031
| +128% | +$30.2K |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.